Login
Navigate Fool.com
Will GNVC beat
the market?

GENVEC, INC. (NASDAQ: GNVC)

Community Rating: 1 Star: Ominous

2.16 -0.04 (-1.82%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.16
Previous Close $2.20
Daily Range $2.14 - $2.19
52-Week Range $0.25 - $4.25
Market Cap $37.3M
P/E Ratio -3.67
Dividend (Yield) $0.00 (0.0%)
Volume 13,861
Average Daily Volume 30,299
Current FY EPS -$0.40

How do you think GNVC
will perform against the market?

Top GNVC Bull/Bear Pitches

 

USMCbeendoinit (0)
Submitted July 13, 2011

I have been doin some research on GenVec and from what I am seeing, GV is headed in the right direction. With the new addition of Doctor Mahmoud and Doctor Connor to the board of directors, I am feeli … More

1 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted October 11, 2013

What's been going through the minds of GenVec management this year? Are they trying to find excuses to keep the company running until they've paid themselves every last cent of remaining cash? Are the … More

4 Replies Reply Report this Post

News & Commentary Rss Feed

GenVec Q4 Net Loss Deepens

The pharmaceutical company lands firmly in the red, but the net result isn't as bad as expected.

Pre-Market Earnings Report for March 28, 2014 : BBRY, FINL, GNVC, JBSAY

Pre-Market Earnings Report for March 28, 2014 : BBRY, FINL, GNVC, JBSAY

Sector Update: Biotech Stocks Helping The NASDAQ

Market Close: Big Winners & Losers for April 11, 2013 (ACAD, RAD, MEA, RDHL, INOC, NTIC, LEDS, DRTX,

Market Close: Big Winners & Losers for April 11, 2013 (ACAD, RAD, MEA, RDHL, INOC, NTIC, LEDS, DRTX, FTNT, GNVC)

Pre-Market Earnings Report for March 22, 2013 : TIF, DRI, GNVC

Pre-Market Earnings Report for March 22, 2013 : TIF, DRI, GNVC

GenVec Gets Conditional License For Foot-And-Mouth Vaccine For Cattle

GenVec, Merial Team up to Develop Food-and-Mouth Disease Vaccine

3 Stocks to Play Biotech

Here are three promising ideas for this exciting area.

UPDATE 1-GenVec shrs plunge after cancer drug trial discontinued

GenVec Halts Phase III Trial Of TNFerade For Pancreatic Cancer

See More GNVC News...

Sector

Healthcare

Industry

Drugs

GENVEC, INC. (GNVC) Description

A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines. Website: http://www.genvec.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks